Bivalency Is Required for Anticapsular Monoclonal Antibodies To Optimally Suppress Activation of the Alternative Complement Pathway by the Cryptococcus neoformans Capsule

Encapsulated cells of Cryptococcus neoformans are potent activators of the alternative complement pathway. Previous studies found that monoclonal antibodies (MAbs) specific for the major capsular polysaccharide, termed glucuronoxylomannan (GXM), can markedly suppress the ability of the capsule to ac...

Descripció completa

Dades bibliogràfiques

Publicat a:	Infect Immun
Autors principals:	Kozel, Thomas R., MacGill, Randall S., Wall, Kevin K.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1998
Matèries:	Fungal and Parasitic Infections
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC108087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9529080/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.66.4.1547-1553.1998
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!